Latest cancer treatment Stories
CTCA takes the patient experience to an even higher level with the launch of Patient Empowered Care(SM) ZION, Ill., Aug. 18, /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern) announced today that it has received the 2010/2011 HealthGrades Outstanding Patient Experience Award(TM) -- one of only 14 recipients in Illinois to receive the prestigious award, and one of only six to be ranked in the top five percent. As the...
In 2006, the U.S. Centers for Disease Control and Prevention recommended routine HIV testing in all healthcare settings as long as patients are given the opportunity to 'opt-out' or refuse the test.That recommendation is not widely followed, but it should be "“ especially in settings where people are treated for cancer, said a group of experts including those at Baylor College of Medicine, in a report in today's issue of the Journal of the American Medical Association.Better response to...
CHICAGO, July 13 /PRNewswire/ -- After a successful pilot program in October 2009, Cancer Treatment Centers of America (CTCA) is introducing an innovative approach to cancer treatment this July at each of its four hospitals in suburban Chicago, Philadelphia, Tulsa and suburban Phoenix. Called "Patient Empowered Care(SM)," this advancement in the patient treatment delivery process offers patients an average of between two and three hours with a dedicated team of specialized oncology...
Scientists have discovered that when they transplant ovaries from young mice into aging female mice, not only does the procedure make the mice fertile again, but also it rejuvenates their behavior and increases their lifespan. The question now is: could ovarian transplants in women have the same effect?Dr Noriko Kagawa told the 26th annual meeting of the European Society of Human Reproduction and Embryology in Rome Tuesday June 29 that successful ovarian transplants increased the lifespan of...
BEVERLY HILLS, Calif., June 10 /PRNewswire/ -- The Center for Radiation Therapy of Beverly Hills, a state-of-the-art cancer treatment center serving cancer patients in the Los Angeles area, has become one of the select facilities in the country to offer its patients the Calypso® System, a prostate cancer treatment tool that enables clinicians to track tumor motion in real-time. Calypso enables physicians to confidently reduce treatment margins while escalating dose to the tumor, thereby...
LEEDS, United Kingdom, May 20 /PRNewswire-FirstCall/ -- Today, in a world first, Asda announces a commitment to sell all privately prescribed cancer treatment drugs on a permanent 'not for profit' basis potentially saving thousands of pounds for sufferers. Lung disease is the biggest cancer killer of women in the UK and as part of Asda's 'not for profit' commitment it now means that the price of Iressa, used to treat lung cancer, is now available for 2,167.71 pounds Sterling compared to...
SEATTLE, April 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are...
Phase 3 X-PECT Trial (Xeloda(R)) + Perifosine Evaluation in Colorectal Cancer Treatment) being conducted by partner Keryx Biopharmaceuticals pursuant to Special Protocol Assessment with the Food and Drug Administration QUEBEC CITY, April 8 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company"), a late-stage drug development company specialized in oncology and endocrine therapy, today announced the initiation of a Phase 3 registration clinical trial with...
NEW YORK, April 8 /PRNewswire/ -- Bayard Advertising Agency, Inc., an integrated branding and communications agency serving B2B and B2C clients in a broad array of industries, announces its selection as Recruitment Advertising Agency of Record by Cancer Treatment Centers of America® (CTCA). Bayard is tasked with creating recruitment marketing and media solutions for CTCA by further developing and spreading its uplifting, compassionate brand message through creative campaigns that are...
LONDON, March 30, 2010 /PRNewswire/ -- - Three out of Four Cancer Patients Unaware of Brachytherapy Former England Rugby World Cup winner Matt Dawson today launched the 'Because Life is for Living' campaign to raise awareness about brachytherapy, a very precise (1) and highly effective (2) form of radiotherapy to treat cancer. To view the Multimedia News Release, please click: http://multivu.prnewswire.com/mnr/nucletron/43245/ Photographs of Matt Dawson...
